Selected research
Market Outlook & Growth Opportunities
Global Helicobacter Pylori Antigen Test Market Outlook and Growth Opportunities 2026
Market perspective
The global Helicobacter Pylori Antigen Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Helicobacter Pylori Antigen Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Helicobacter Pylori Antigen Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Helicobacter Pylori Antigen Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Helicobacter Pylori Antigen Test market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Helicobacter Pylori Antigen Test market include Abbott Laboratories, Thermo Fisher Scientific, CerTest Biotec, GUANGZHOU WONDFO BIOTECH CO.,LTD, Getein Biotech,Inc, Zhejiang Orient Gene Biotech Co.,Ltd., Denka Company Limited, ACON Laboratories Inc and Coris Bioconcept SRL, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Helicobacter Pylori Antigen Test market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Helicobacter Pylori Antigen Test and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Helicobacter Pylori Antigen Test revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Helicobacter Pylori Antigen Test market.
Helicobacter Pylori Antigen Test Segment by Company
Abbott Laboratories
Thermo Fisher Scientific
CerTest Biotec
GUANGZHOU WONDFO BIOTECH CO.,LTD
Getein Biotech,Inc
Zhejiang Orient Gene Biotech Co.,Ltd.
Denka Company Limited
ACON Laboratories Inc
Coris Bioconcept SRL
Biosynex SA
CTK Biotech, Inc.
Humasis Co., Ltd.
Assure Tech(HangZhou) Co., Ltd.
Hangzhou Biotest Biotech Co.,Ltd.
Xiamen Boson Biotech
MP Biomedicals
Diagnostic Automation
DRG Diagnostics
Epitope Diagnostics
SD Biosensor
DiaSorin
QuidelOrtho
Helicobacter Pylori Antigen Test Segment by Type
Carbon-13 Breath Test
Carbon-14 Breath Test
Helicobacter Pylori Antigen Test Segment by Application
Medical and Health
Public Health
Medical Examination Services
Other
Helicobacter Pylori Antigen Test Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Helicobacter Pylori Antigen Test status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Helicobacter Pylori Antigen Test key companies, revenue, market share, and recent developments.
3. To split the Helicobacter Pylori Antigen Test breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Helicobacter Pylori Antigen Test market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Helicobacter Pylori Antigen Test significant trends, drivers, influence factors in global and regions.
6. To analyze Helicobacter Pylori Antigen Test competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Helicobacter Pylori Antigen Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Helicobacter Pylori Antigen Test and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Helicobacter Pylori Antigen Test.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Helicobacter Pylori Antigen Test industry.
Chapter 3: Detailed analysis of Helicobacter Pylori Antigen Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Helicobacter Pylori Antigen Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Helicobacter Pylori Antigen Test in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Carbon-13 Breath Test
- Carbon-14 Breath Test
Applications
- Medical and Health
- Public Health
- Medical Examination Services
- Other
Companies covered
- Abbott Laboratories
- Thermo Fisher Scientific
- CerTest Biotec
- GUANGZHOU WONDFO BIOTECH CO.,LTD
- Getein Biotech,Inc
- Zhejiang Orient Gene Biotech Co.,Ltd.
- Denka Company Limited
- ACON Laboratories Inc
- Coris Bioconcept SRL
- Biosynex SA
- CTK Biotech, Inc.
- Humasis Co., Ltd.
- Assure Tech(HangZhou) Co., Ltd.
- Hangzhou Biotest Biotech Co.,Ltd.
- Xiamen Boson Biotech
- MP Biomedicals
- Diagnostic Automation
- DRG Diagnostics
- Epitope Diagnostics
- SD Biosensor
- DiaSorin
- QuidelOrtho
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Helicobacter Pylori Antigen Test Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Helicobacter Pylori Antigen Test Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Helicobacter Pylori Antigen Test Market Dynamics
- 2.1 Helicobacter Pylori Antigen Test Industry Trends
- 2.2 Helicobacter Pylori Antigen Test Industry Drivers
- 2.3 Helicobacter Pylori Antigen Test Industry Opportunities and Challenges
- 2.4 Helicobacter Pylori Antigen Test Industry Restraints
3 Helicobacter Pylori Antigen Test Market by Company
- 3.1 Global Helicobacter Pylori Antigen Test Company Revenue Ranking in 2025
- 3.2 Global Helicobacter Pylori Antigen Test Revenue by Company (2021-2026)
- 3.3 Global Helicobacter Pylori Antigen Test Company Ranking (2024-2026)
- 3.4 Global Helicobacter Pylori Antigen Test Company Manufacturing Base and Headquarters
- 3.5 Global Helicobacter Pylori Antigen Test Company Product Type and Application
- 3.6 Global Helicobacter Pylori Antigen Test Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Helicobacter Pylori Antigen Test Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Helicobacter Pylori Antigen Test Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Helicobacter Pylori Antigen Test Market by Type
- 4.1 Helicobacter Pylori Antigen Test Type Introduction
- 4.1.1 Carbon-13 Breath Test
- 4.1.2 Carbon-14 Breath Test
- 4.2 Global Helicobacter Pylori Antigen Test Sales Value by Type
- 4.2.1 Global Helicobacter Pylori Antigen Test Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Helicobacter Pylori Antigen Test Sales Value by Type (2021-2032)
- 4.2.3 Global Helicobacter Pylori Antigen Test Sales Value Share by Type (2021-2032)
5 Helicobacter Pylori Antigen Test Market by Application
- 5.1 Helicobacter Pylori Antigen Test Application Introduction
- 5.1.1 Medical and Health
- 5.1.2 Public Health
- 5.1.3 Medical Examination Services
- 5.1.4 Other
- 5.2 Global Helicobacter Pylori Antigen Test Sales Value by Application
- 5.2.1 Global Helicobacter Pylori Antigen Test Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Helicobacter Pylori Antigen Test Sales Value by Application (2021-2032)
- 5.2.3 Global Helicobacter Pylori Antigen Test Sales Value Share by Application (2021-2032)
6 Helicobacter Pylori Antigen Test Regional Value Analysis
- 6.1 Global Helicobacter Pylori Antigen Test Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Helicobacter Pylori Antigen Test Sales Value by Region (2021-2032)
- 6.2.1 Global Helicobacter Pylori Antigen Test Sales Value by Region: 2021-2026
- 6.2.2 Global Helicobacter Pylori Antigen Test Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Helicobacter Pylori Antigen Test Sales Value (2021-2032)
- 6.3.2 North America Helicobacter Pylori Antigen Test Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Helicobacter Pylori Antigen Test Sales Value (2021-2032)
- 6.4.2 Europe Helicobacter Pylori Antigen Test Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Helicobacter Pylori Antigen Test Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Helicobacter Pylori Antigen Test Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Helicobacter Pylori Antigen Test Sales Value (2021-2032)
- 6.6.2 South America Helicobacter Pylori Antigen Test Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Helicobacter Pylori Antigen Test Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Helicobacter Pylori Antigen Test Sales Value Share by Country, 2025 VS 2032
7 Helicobacter Pylori Antigen Test Country-level Value Analysis
- 7.1 Global Helicobacter Pylori Antigen Test Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Helicobacter Pylori Antigen Test Sales Value by Country (2021-2032)
- 7.2.1 Global Helicobacter Pylori Antigen Test Sales Value by Country (2021-2026)
- 7.2.2 Global Helicobacter Pylori Antigen Test Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.7.2 France Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.14.2 China Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.17.2 India Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Abbott Laboratories
- 8.1.1 Abbott Laboratories Company Information
- 8.1.2 Abbott Laboratories Business Overview
- 8.1.3 Abbott Laboratories Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 8.1.4 Abbott Laboratories Helicobacter Pylori Antigen Test Product Portfolio
- 8.1.5 Abbott Laboratories Recent Developments
- 8.2 Thermo Fisher Scientific
- 8.2.1 Thermo Fisher Scientific Company Information
- 8.2.2 Thermo Fisher Scientific Business Overview
- 8.2.3 Thermo Fisher Scientific Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 8.2.4 Thermo Fisher Scientific Helicobacter Pylori Antigen Test Product Portfolio
- 8.2.5 Thermo Fisher Scientific Recent Developments
- 8.3 CerTest Biotec
- 8.3.1 CerTest Biotec Company Information
- 8.3.2 CerTest Biotec Business Overview
- 8.3.3 CerTest Biotec Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 8.3.4 CerTest Biotec Helicobacter Pylori Antigen Test Product Portfolio
- 8.3.5 CerTest Biotec Recent Developments
- 8.4 GUANGZHOU WONDFO BIOTECH CO.,LTD
- 8.4.1 GUANGZHOU WONDFO BIOTECH CO.,LTD Company Information
- 8.4.2 GUANGZHOU WONDFO BIOTECH CO.,LTD Business Overview
- 8.4.3 GUANGZHOU WONDFO BIOTECH CO.,LTD Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 8.4.4 GUANGZHOU WONDFO BIOTECH CO.,LTD Helicobacter Pylori Antigen Test Product Portfolio
- 8.4.5 GUANGZHOU WONDFO BIOTECH CO.,LTD Recent Developments
- 8.5 Getein Biotech,Inc
- 8.5.1 Getein Biotech,Inc Company Information
- 8.5.2 Getein Biotech,Inc Business Overview
- 8.5.3 Getein Biotech,Inc Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 8.5.4 Getein Biotech,Inc Helicobacter Pylori Antigen Test Product Portfolio
- 8.5.5 Getein Biotech,Inc Recent Developments
- 8.6 Zhejiang Orient Gene Biotech Co.,Ltd.
- 8.6.1 Zhejiang Orient Gene Biotech Co.,Ltd. Company Information
- 8.6.2 Zhejiang Orient Gene Biotech Co.,Ltd. Business Overview
- 8.6.3 Zhejiang Orient Gene Biotech Co.,Ltd. Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 8.6.4 Zhejiang Orient Gene Biotech Co.,Ltd. Helicobacter Pylori Antigen Test Product Portfolio
- 8.6.5 Zhejiang Orient Gene Biotech Co.,Ltd. Recent Developments
- 8.7 Denka Company Limited
- 8.7.1 Denka Company Limited Company Information
- 8.7.2 Denka Company Limited Business Overview
- 8.7.3 Denka Company Limited Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 8.7.4 Denka Company Limited Helicobacter Pylori Antigen Test Product Portfolio
- 8.7.5 Denka Company Limited Recent Developments
- 8.8 ACON Laboratories Inc
- 8.8.1 ACON Laboratories Inc Company Information
- 8.8.2 ACON Laboratories Inc Business Overview
- 8.8.3 ACON Laboratories Inc Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 8.8.4 ACON Laboratories Inc Helicobacter Pylori Antigen Test Product Portfolio
- 8.8.5 ACON Laboratories Inc Recent Developments
- 8.9 Coris Bioconcept SRL
- 8.9.1 Coris Bioconcept SRL Company Information
- 8.9.2 Coris Bioconcept SRL Business Overview
- 8.9.3 Coris Bioconcept SRL Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 8.9.4 Coris Bioconcept SRL Helicobacter Pylori Antigen Test Product Portfolio
- 8.9.5 Coris Bioconcept SRL Recent Developments
- 8.10 Biosynex SA
- 8.10.1 Biosynex SA Company Information
- 8.10.2 Biosynex SA Business Overview
- 8.10.3 Biosynex SA Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 8.10.4 Biosynex SA Helicobacter Pylori Antigen Test Product Portfolio
- 8.10.5 Biosynex SA Recent Developments
- 8.11 CTK Biotech, Inc.
- 8.11.1 CTK Biotech, Inc. Company Information
- 8.11.2 CTK Biotech, Inc. Business Overview
- 8.11.3 CTK Biotech, Inc. Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 8.11.4 CTK Biotech, Inc. Helicobacter Pylori Antigen Test Product Portfolio
- 8.11.5 CTK Biotech, Inc. Recent Developments
- 8.12 Humasis Co., Ltd.
- 8.12.1 Humasis Co., Ltd. Company Information
- 8.12.2 Humasis Co., Ltd. Business Overview
- 8.12.3 Humasis Co., Ltd. Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 8.12.4 Humasis Co., Ltd. Helicobacter Pylori Antigen Test Product Portfolio
- 8.12.5 Humasis Co., Ltd. Recent Developments
- 8.13 Assure Tech(HangZhou) Co., Ltd.
- 8.13.1 Assure Tech(HangZhou) Co., Ltd. Company Information
- 8.13.2 Assure Tech(HangZhou) Co., Ltd. Business Overview
- 8.13.3 Assure Tech(HangZhou) Co., Ltd. Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 8.13.4 Assure Tech(HangZhou) Co., Ltd. Helicobacter Pylori Antigen Test Product Portfolio
- 8.13.5 Assure Tech(HangZhou) Co., Ltd. Recent Developments
- 8.14 Hangzhou Biotest Biotech Co.,Ltd.
- 8.14.1 Hangzhou Biotest Biotech Co.,Ltd. Company Information
- 8.14.2 Hangzhou Biotest Biotech Co.,Ltd. Business Overview
- 8.14.3 Hangzhou Biotest Biotech Co.,Ltd. Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 8.14.4 Hangzhou Biotest Biotech Co.,Ltd. Helicobacter Pylori Antigen Test Product Portfolio
- 8.14.5 Hangzhou Biotest Biotech Co.,Ltd. Recent Developments
- 8.15 Xiamen Boson Biotech
- 8.15.1 Xiamen Boson Biotech Company Information
- 8.15.2 Xiamen Boson Biotech Business Overview
- 8.15.3 Xiamen Boson Biotech Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 8.15.4 Xiamen Boson Biotech Helicobacter Pylori Antigen Test Product Portfolio
- 8.15.5 Xiamen Boson Biotech Recent Developments
- 8.16 MP Biomedicals
- 8.16.1 MP Biomedicals Company Information
- 8.16.2 MP Biomedicals Business Overview
- 8.16.3 MP Biomedicals Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 8.16.4 MP Biomedicals Helicobacter Pylori Antigen Test Product Portfolio
- 8.16.5 MP Biomedicals Recent Developments
- 8.17 Diagnostic Automation
- 8.17.1 Diagnostic Automation Company Information
- 8.17.2 Diagnostic Automation Business Overview
- 8.17.3 Diagnostic Automation Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 8.17.4 Diagnostic Automation Helicobacter Pylori Antigen Test Product Portfolio
- 8.17.5 Diagnostic Automation Recent Developments
- 8.18 DRG Diagnostics
- 8.18.1 DRG Diagnostics Company Information
- 8.18.2 DRG Diagnostics Business Overview
- 8.18.3 DRG Diagnostics Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 8.18.4 DRG Diagnostics Helicobacter Pylori Antigen Test Product Portfolio
- 8.18.5 DRG Diagnostics Recent Developments
- 8.19 Epitope Diagnostics
- 8.19.1 Epitope Diagnostics Company Information
- 8.19.2 Epitope Diagnostics Business Overview
- 8.19.3 Epitope Diagnostics Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 8.19.4 Epitope Diagnostics Helicobacter Pylori Antigen Test Product Portfolio
- 8.19.5 Epitope Diagnostics Recent Developments
- 8.20 SD Biosensor
- 8.20.1 SD Biosensor Company Information
- 8.20.2 SD Biosensor Business Overview
- 8.20.3 SD Biosensor Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 8.20.4 SD Biosensor Helicobacter Pylori Antigen Test Product Portfolio
- 8.20.5 SD Biosensor Recent Developments
- 8.21 DiaSorin
- 8.21.1 DiaSorin Company Information
- 8.21.2 DiaSorin Business Overview
- 8.21.3 DiaSorin Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 8.21.4 DiaSorin Helicobacter Pylori Antigen Test Product Portfolio
- 8.21.5 DiaSorin Recent Developments
- 8.22 QuidelOrtho
- 8.22.1 QuidelOrtho Company Information
- 8.22.2 QuidelOrtho Business Overview
- 8.22.3 QuidelOrtho Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
- 8.22.4 QuidelOrtho Helicobacter Pylori Antigen Test Product Portfolio
- 8.22.5 QuidelOrtho Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst